RNS Number : 8101O
PipeHawk PLC
17 May 2024
 

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018) ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

17 May 2024

PipeHawk plc

("PipeHawk", "Company" or the "Group")

 

£0.75 million contract award

 

PipeHawk is pleased to announce that QM Systems Limited ("QM"), a subsidiary of PipeHawk plc, has been awarded a contract with a leading building materials business (the "Customer") to deliver an assembly line for the manufacture of flooring tile assemblies. The project will generate revenues of approximately £750k and will take approximately 10 months to deliver. The project will utilise QM's core skills in component handling for the building services industry to provide a bespoke assembly and handling system.

 

Gordon Watt, Chairman of PipeHawk commented: "This is incredibly exciting news for QM and cements an already established partnership built over the last few years between the Customer and QM Systems."

 

-Ends-

 

Enquiries:

 

PipeHawk plc

Gordon Watt (Chairman)

 

Tel. No. 01252 338 959

Allenby Capital Limited (Nomad and Broker)

Tel. No. 020 3328 5656

David Hart / Vivek Bhardwaj

 

For further information on the Company and its subsidiaries, please visit:  www.pipehawk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTUNVNRSVUVAAR